FDA approves first generic version of depression drug Lexapro
by foxnews.com
The U.S. Food and Drug administration approved the first generic Lexapro (escitalopram tablets) for the treatment of both depression and generalized anxiety disorder in adults, the government organization announced Wednesday.
People with depression typically suffer from feelings of guilt and worthlessness that interfere with their ability to work, sleep, study, eat and enjoy other activities, while people with general anxiety disorder (GAD) suffer from exaggerated worry and tension. Both conditions can recur throughout a person’s lifetime.
“These psychiatric conditions can be disabling and prevent a person from doing every-day activities,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in an FDA press release. “This medication is widely used by people who must manage their condition over time, so it is important to have affordable treatment options.”
The FDA granted Teva Pharmaceutical Industries/IVAX Pharmaceuticals to market generic escitalopram in 5 milligram, 10 mg, and 20 mg strengths. Teva has been granted a 180-day period of generic drug exclusivity, meaning the FDA cannot approve another generic version of escitalopram.
Teva’s escitalopram tablets must meet the same quality standards as the brand-name drugs.
Source: http://www.foxnews.com/health/2012/03/14/fda-approves-first-generic-version-depression-drug-lexapro.html
Lexapro (escitalopram) is an orally administered selective serotonin reuptake inhibitor (SSRI) which can be ordered from http://corn-crake.tumblr.com/lexapro-escitalopram/. Lexapro is available as tablets or as an oral solution.
Tuesday, May 12, 2026
Using Generic Options Wisely in Urinary Infection Treatment Plans
Generic medicine questions often appear during urinary infection treatment, especially when patients want affordable care without compromising recovery. The most useful way to approach these questions is to keep diagnosis and treatment fit at the center of every decision. Urinary symptoms can overlap with non infectious causes, so proper evaluation remains essential before selecting therapy. Even when a medicine is familiar by name, treatment should match current symptoms, severity, and clinical findings. Relying on assumptions can delay effective care. When discussing generic alternatives, patients should ask about equivalence, dosing schedule, and side effect expectations. These details help prevent confusion during treatment and support stronger adherence from the first day to the final dose. If you are reviewing nitrofurantoin generic information, combine that reading with guidance from a clinician or pharmacist. Ask whether the option is appropriate for your current condition and how to respond if symptoms do not improve as expected. Adherence remains critical regardless of product type. Missed doses or early discontinuation after partial relief can increase recurrence risk. Practical tools such as alarms, pill organizers, and simple logs can improve completion rates. Supportive steps still matter. Hydration, rest, and daily symptom notes can improve comfort and provide valuable follow up data if reassessment is needed. Urgent warning signs require immediate medical attention, including fever with back pain, severe nausea, confusion, or worsening urinary discomfort despite treatment. Waiting too long can increase complications. Patients should avoid sharing medication or reusing leftovers from prior episodes. Similar symptoms may have different causes, and current evaluation is often necessary for safe treatment selection. For broader context on responsible medication choices, reviewing reliable information about antibiotic stewardship can support safer decisions. Generic options can play an effective role when they are integrated into accurate diagnosis, clear instructions, and consistent follow through.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.